Results 1 - 25 from 33 for "gsk"
-
Antitrust Body Looks Into Sandoz AG’s Acquisition Of Business Activity From GSK
04.26.2021
Romania’s Competition Council is looking into a transaction whereby Sandoz AG seeks to acquire from GlaxoSmithKline (GSK) the sale activity of cephalosporine-based antibiotics. more
-
GSK’s Prescription Drugs and Vaccine Division Exits Romania
10.07.2020
Pharmaceutical giant GlaxoSmithKline, which has been operating in Romania for almost 30 years now, has decided to close its pharmaceutical representative office in the country. more
-
Dana Constantinescu Runs GSK Romania Operations
04.02.2018
-
GSK Consumer Healthcare Names New GM For Romania And Balkan States
01.11.2017
GlaxoSmithKline (GSK) Consumer Healthcare has appointed Sylwia Piankowska as general manager for Romania and the Balkan states, replacing Helen Tomlinson, who was named general manager of GSK Consumer more
-
GSK Market Share Down To Half In Ten Years
05.03.2016
UK’s GlaxoSmithKline (GSK), which had drug production operations in Romania via the Europharm plant in Brasov since late nineties, has lost more than half of its market share in Romania on the drug more
-
GSK Romania Invested Over EUR3M In Clinical Trials In 2014-2015
04.27.2016
GSK (GlaxoSmithKline) Romania invested over EUR3 million in the last two years in research and development, in clinical trials, focusing on five therapeutic areas, namely respiratory, HIV, vaccines, more
-
End Of The Road For GSK’s Europharm Plant
02.08.2016
UK’s pharmaceutical group GSK finally closed the Europharm plant in Brasov County, central Romania, last year, completing the implementation a plan it had devised for the facility years ago. more
-
Europharm Turnover Up 7% In 2013, When GSK Announced Shutdown
10.30.2014
GlaxoSmithKline's Romanain production line Europharm in Brasov, which will be shut down next year, had a turnover of RON497 million (EUR113 million) in 2013, the year the future shutdown was more
-
How Much Did Europharm Bring GSK In More Than A Decade?
07.15.2014
Romanian medicine plant Europharm, owned by GlaxoSmithKline (GSK) which plans to close it by the end of next year, generated overall revenue worth EUR576 million and net profit of EUR28 million in the more
-
Why Romanian Plants Cannot Be Saved From Closing
06.18.2014
No Romanian entrepreneur has the financial strength to buy a EUR100 million plant, while the lack of funding and a business environment that is unfriendly to Romanian investors prevent them from more
-
GSK Fails To Find Buyer For Its Europharm Plant in Brasov, Sets Off Shutdown Procedures
06.12.2014
British pharmaceutical group GlaxoSmithKline (GSK) has decided to close down its medicine production line in Brasov, central Romania, after it failed to find a buyer, the company said in a statement more
-
GSK Appoints Marketing Manager As Interim General Manager Of Europharm Distributie
05.22.2014
UK’s GlaxoSmithKline (GSK), which owns pharmaceutical distributor Europharm Distributie, has appointed marketing manager Viorel Vodita as interim general manager. more
-
Romanians Use One Toothpaste Tube A Year And Change Their Toothbrush Once Every Two Years
05.21.2014
Giants Colgate-Palmolive, Procter&Gamble and GlaxoSmithKline control around 80% of Romania’s EUR45-50 million toothpaste market. US Colgate-Palmolive is market leader in all Central and Eastern more
-
GSK Romania Has New GM Starting April 1
03.21.2014
Barbara Cygler has been appointed general manager of GlaxoSmithKline’s Romanian subsidiary and will take over the new position starting April 1, 2014. more
-
Fate Of GSK's Europharm Plant in Brasov Still Undecided
03.18.2014
The deadline GlaxoSmithKline (GSK) set for finding a buyer for its pharmaceutical plant Europharm in Brasov expires at the end of the month. more
-
GSK: 2014 A Year Of Transition After Patent Expiration For Best-Selling Drug
02.11.2014
The year 2014 will be a transition year for GlaxoSmithKline Romania, as the sales will be affected by the expiration of the patent for the best-selling drug in its portfolio, which will now see more
-
GSK Romania Used EUR66.8M Capital Hike To Pay Off Debts
01.16.2014
GSK Romania used the EUR66.8 million from its recent share capital raise to pay off debts to other divisions of the British pharmaceutical group, amassed due to extensive payment terms on the Romanian more
-
GSK Romania Hiked Share Capital By EUR66.8M In December
01.15.2014
GlaxoSmithKline’s Romanian subsidiary hiked in December its share capital by 298.2million lei (EUR66.8 million), according to the Trade Registry data. more
-
How GSK Decided To Give Up Its Plant In Brasov
12.25.2013
The announcement of British drugmaker GlaxoSmithKline (GSK) about giving up its Europharm plant in Brasov, central Romania, came as a shock to the pharmaceutical industry this summer. more
-
GSK Hopes To Select Buyer For Its Medicines Factory In Brasov By End 1Q/2014
12.12.2013
British pharmaceutical group GlaxoSmithKline (GSK) Thursday said it expects to select a buyer for its medicines production line in Brasov, central Romania, by the end of the first quarter in 2014. more
-
Prigent, GSK Romania: Local Healthcare System Needs Investments, Increased Efficiency
09.23.2013
Romania’s healthcare system needs more investments and increased efficiency, Pascal Prigent, general manager of GlaxoSmithKline (GSK) Romania, said Monday. more
-
GSK Receives Several Offers For Its Europharm Production Facility In Brasov, Romania
09.02.2013
British pharmaceutical group GlaxoSmithKline has received more offers than it expected for its production line in Brasov, central Romania, both from local and international investors, GSK Romania more
-
GSK Sponsored 211 Romanian Doctors To Attend Medical Congresses In 2012
08.28.2013
Healthcare company GlaxoSmithKline (GSK), the sixth largest player in the Romanian medicine industry, announced it provided funding last year for 211 Romanian doctors to attend 40 international more
-
GSK Romania Sales Slightly Down In 2012 On Increased Competition For Generics
06.30.2013
Sales of GlaxoSmithKline’s Romanian subsidiary declined slightly last year to RON637.4 million from RON643.8 million in 2011, according to Cegedim data, which GSK Romania manager Pascal Prigent said more
-
GlaxoSmithKline To Close Its Medicines Factory In Brasov Unless It Finds Buyer
06.27.2013
GSK Romania is seeking a buyer for its medicines production line in Brasov, central Romania, which it will otherwise shut down in 2015. more